How Has The Adenosine Triphosphate (ATP) Assays Market Size Evolved In Recent Years?
The adenosine triphosphate (atp) assays market has seen considerable growth due to a variety of factors.
•In the past few years, there has been a swift growth in the market size for adenosine triphosphate (ATP) assays. The market, valued at $1.99 billion in 2024, is projected to increase to $2.2 billion by 2025, experiencing a compound annual growth rate (CAGR) of 10.7%.
This growth during the historic period can be attributed to the advancements in biomedical research, progress in drug discovery and development, rising adoption in clinical diagnostics, requirements for environmental monitoring, and an increased focus on cell-based assays.
What Is The Projected Growth Of The Adenosine Triphosphate (ATP) Assays Market?
The adenosine triphosphate (atp) assays market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for adenosine triphosphate (ATP) assays exhibits a promising trajectory for substantial expansion in the upcoming years, with a projected rise to "$3.46 billion in 2029 and a compound annual growth rate (CAGR) of 12.0%.
The surge in this forecasted period can be accredited to the perpetuated evolution of the biopharmaceutical sector, the proliferation of personalized medicine techniques, heightened focus on the safety of food & beverages, progression in assay technology platforms, and their escalating usage in industrial operations. Noteworthy trends in the forecast period encompass enhancements in ATP detection technologies, a climbing need for high-throughput screening, incorporation into clinical diagnostics, focus on food & beverage safety examinations, and application in sports and performance assessment.
What Are The Key Drivers Fueling Growth In The Adenosine Triphosphate (ATP) Assays Market?
A surge in the prevalence of cancer, chronic, and infectious illnesses is predicted to drive the adenosine triphosphate (ATP) assay market's growth. Cancer involves unregulated cell proliferation, which can harm neighboring tissues and potentially disseminate to other parts of the body. Chronic illnesses are consistent states that generally proceed at a slow pace and linger over a long duration. Infectious diseases are caused by pathogenic microbes that can transmit from one person to another, such as bacteria, viruses, fungi, or parasites. ATP assays serve as a critical resource in treating these diseases by evaluating cellular health, identifying microbial infection, assessing treatment effectiveness, and tracking metabolic and mitochondrial malfunctions. The World Health Organization, a United Nations entity in Switzerland, projected in February 2024 that over 35 million new cancer instances would emerge by 2050, signaling a 77% surge compared to the predicted 20 million instances in 2022. Moreover, the International Diabetes Federation, a Belgium-based global institution supporting the diabetes community, revealed in 2021 that around 537 million adults are diabetic, a figure expected to increase to 783 million by 2045. Hence, the escalating prevalence of cancer, chronic, and infectious illnesses augments the growth of the adenosine triphosphate (ATP) assay market.
What Are The Principal Market Segments In The Global Adenosine Triphosphate (ATP) Assays Industry?
The adenosine triphosphate (ATP) assays market covered in this report is segmented –
1) By Type: Luminometric ATP (Adenosine Triphosphate) Assays, Enzymatic ATP (Adenosine Triphosphate) Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays, Cell-Based ATP (Adenosine Triphosphate) Assays, Other Types
2) By Component: Consumables And Accessories, Instruments
3) By Application: Drug Discovery And Development, Clinical Diagnostics, Environmental Testing, Food Safety And Quality Testing, Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies, Food and Beverage Industry, Hospitals And Diagnostics Laboratories, Academic And Research Institutions
Subsegments:
1) By Luminometric ATP Assays: Luciferase-Based Assays, Chemiluminescent Assays
2) By Enzymatic ATP Assays: Kinase-Based Assays, ATPase Activity Assays
3) By Bioluminescence Resonance Energy Transfer (BRET) ATP Assays: BRET For Protein-Protein Interactions, BRET For Drug Discovery
4) By Cell-Based ATP Assays: Live-Cell ATP Measurement, Cell Viability Assays
5) By Other Types: Fluorescent ATP Assays, Spectrophotometric ATP Assays
Pre-Book The Adenosine Triphosphate (ATP) Assays Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Adenosine Triphosphate (ATP) Assays Sector?
There is a growing trend in the adenosine triphosphate (ATP) assay market towards the creation of innovative assays. To maintain their market standing, leading companies in this sector are bringing to market groundbreaking products such as the SensiLux kits. For instance, SensiLux kits, a product of BC Aplicaciones, a biotech firm based in Spain, is a revolutionary kit meant to detect the presence of microbial ATP within samples. What sets this product apart is its use of bioluminescence to identify microbial ATP presence in pre-incubated samples – a function that's particularly valuable in food safety and contamination examinations. Moreover, they offer ATP kits that are equipped with potent automatic luminometers with multi-injectors, exclusive control software, and potential robot-based sample automation to deliver fully personalised solutions to clients. The software that regulates robot and luminometer functioning was specially conceptualised and created by their in-house programming and computer systems division.
Who Are the Key Players in the Adenosine Triphosphate (ATP) Assays Market?
Major companies operating in the adenosine triphosphate (ATP) assays market include:
• Merck KGaA
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Lonza Group
• Promega Corporation
• Agilent Technologies Inc.
• Abcam plc
• Danaher Corporation
• 3M Co.
• Geno Technology Inc.
• NEOGEN Corporation
• Biomerieux SA
• AAT Bioquest Inc.
• MBL International Corporation
• Charm Sciences Inc.
• Cell Signaling Technology Inc.
• Cayman Chemical Company
• Vazyme Biotech Co. Ltd.
• SignalChem Lifesciences Corporation
• Kaneka Corporation
• Novus Biologicals LLC
• NANOGEN Biotechnologies Inc.
• Nacalai Tesque Inc.
• MoBiTec GmbH
• Lumigen Inc.
• Jena Bioscience GmbH
• Goryo Chemical Inc.
• Cosmo Bio Co. Ltd.
• BPS Bioscience Inc.
• BioTek Instruments Inc.
What are the Regional Insights into the Adenosine Triphosphate (ATP) Assays Market?
North America was the largest region in the adenosine triphosphate (ATP) assays market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adenosine triphosphate (ATP) assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
